Pfizer hit with multi-plaintiff suit over anti-seizure drug Dilantin
Pfizer Inc has been sued by 10 people alleging the company and its subsidiaries failed to warn of the risk of severe brain damage from its anti-seizure medication Dilantin.
The plaintiffs in their Wednesday lawsuit in New York Supreme Court alleged Pfizer and its subsidiaries Parke-Davis, Pharmacia and Warner–Lambert have been aware of the risk...
FDA warns against vaginal laser treatments; procedure offered in Rapid City
Federal regulators are warning women about potential risks associated with laser treatments that are being marketed across the nation, including in Rapid City.
On July 30, the U.S. Food and Drug Administration cautioned against the use of energy-based “vaginal rejuvenation” devices, including lasers, to treat problems related to menopause, urinary incontinence and sexual function.
“These products...
Affimed puts on hold cancer drug trial after patient death
Oct 8 (Reuters) - Drug developer Affimed N.V. on Monday put on hold the testing of its experimental cancer drug following the death of a patient and two life-threatening events.
The company’s shares slumped 25 percent to $3.82 in after-market trading.
Read More
U.S. arm of JBS recalls 6.5 million pounds of beef on salmonella risk
CHICAGO/SAO PAULO (Reuters) - A U.S. unit of Brazil’s JBS SA is recalling 6.5 million pounds of beef products processed through an Arizona plant because the meat might be contaminated with salmonella, U.S. government officials said on Thursday.
U.S. investigators have identified at least 57 people in 16 states who have become ill due to...
Senate passes multi-pronged legislation to battle nation’s opioid crisis
WASHINGTON - The Senate easily passed bipartisan legislation Wednesday to combat the nation’s opioid crisis by bolstering programs to treat addiction, more closely monitoring of prescriptions and updating information on alternative treatments to addictive drugs.
The bill passed 98 to one – Sen. Mike Lee, R-Utah was the lone “no” vote and Sen. Ted Cruz,...
House overwhelmingly passes bill to fight opioid crisis
The House on Friday overwhelmingly passed legislation meant to fight the opioid epidemic, a moment of bipartisanship amid a series of fierce partisan battles.
The bill, which passed 393-8, is the product of months of work in both chambers. The Senate is expected to soon send the measure to President Trump’s desk.
Read...
The Health 202: Congress reaches deal on major opioids’ package
Congress could send its sweeping opioids' package to President Trump by week's end after lawmakers reached an agreement late Tuesday night on a final bill to address the nation's public health crisis.
Several issues held up negotiations, but the biggest controversy had nothing to do with opioids at all.
News broke last week that...
Big Pharma Boosts Drug Prices As Supplies Run Low, Study Reveals
Federal lawmakers have been griping about drug pricing for years, led most recently by President Donald Trump, who famously declared even before he was elected that the industry is “getting away with murder.” A new study could very well fuel those complaints.
Researchers at the University of Pittsburgh and Harvard Medical School scoured the U.S....
Lawmakers unveil massive bipartisan bill aimed at fighting opioid crisis
Bipartisan congressional leaders in both chambers on Tuesday night unveiled a massive bill aimed at fighting the epidemic of opioid abuse in the United States, capping months of work.
Fighting the crisis has been an area of bipartisan cooperation this year amid many fierce partisan battles raging with more publicity.
The 660-page bill takes a wide...
Silicone Breast Implants Linked to Autoimmune Complications
Silicone breast implants were associated with increased rates of a variety of autoimmune complications, as well as melanoma and stillbirth -- and the FDA had something to say about it.
A review of data from the FDA's large post approval studies database found that silicone implants were linked to higher rates of Sjögren syndrome, scleroderma,...
